Association between non-alcoholic fatty liver disease and peripheral artery disease in patients with type 2 diabetes.

about

Association between non-alcoholic fatty liver disease and peripheral artery disease in patients with type 2 diabetes.

Item

http://www.wikidata.org/entity/Q48144953

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Association between non-alcoho ...... patients with type 2 diabetes.

@en

Association between non-alcoho ...... patients with type 2 diabetes.

@nl

type

Item

label

Association between non-alcoho ...... patients with type 2 diabetes.

@en

Association between non-alcoho ...... patients with type 2 diabetes.

@nl

prefLabel

Association between non-alcoho ...... patients with type 2 diabetes.

@en

Association between non-alcoho ...... patients with type 2 diabetes.

@nl

P1476

Association between non-alcoho ...... patients with type 2 diabetes.

@en

P2093

Can Wang

http://www.w3.org/2001/XMLSchema#string

Fei Wang

http://www.w3.org/2001/XMLSchema#string

Jing Wang

http://www.w3.org/2001/XMLSchema#string

Lidan Ma

http://www.w3.org/2001/XMLSchema#string

Wenjun You

http://www.w3.org/2001/XMLSchema#string

Xinde Li

http://www.w3.org/2001/XMLSchema#string

Yaowu Zou

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology

C-reactive protein and incident cardiovascular events among men with diabetes

Inflammation and atherosclerosis

Nonalcoholic fatty liver disease

The protective effects of estrogen on the cardiovascular system.

Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta.

G protein-coupled estrogen receptor protects from atherosclerosis

Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004.

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

P304

1147-1153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IMJ.13549

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Changgui Li

P577

2017-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28696562

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes